{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:31:04Z","timestamp":1787679064874,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40292-018-0288-6","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T03:50:36Z","timestamp":1541821836000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor"],"prefix":"10.1007","volume":"25","author":[{"given":"Marco","family":"Grasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-8716","authenticated-orcid":false,"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,10]]},"reference":[{"issue":"28","key":"288_CR1","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht151\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"19","key":"288_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","volume":"35","author":"SF Rimoldi","year":"2014","unstructured":"Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35(19):1245\u201354. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht534\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"25","key":"288_CR3","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","volume":"117","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510\u201326. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.189141\n                    \n                  .","journal-title":"Circulation"},{"issue":"June","key":"288_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2016.00072","volume":"7","author":"N Ghorayeb El","year":"2016","unstructured":"El Ghorayeb N, Bourdeau I, Lacroix A. Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism. Front Endocrinol (Lausanne). 2016;7(June):1\u201310. \n                    https:\/\/doi.org\/10.3389\/fendo.2016.00072\n                    \n                  .","journal-title":"Front Endocrinol (Lausanne)"},{"key":"288_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/978-3-319-27318-1_16-1","volume-title":"Principles of endocrinology and hormone action","author":"F Ceccato","year":"2016","unstructured":"Ceccato F, Scaroni C, Boscaro M. The adrenal glands. In: Belfiore A, LeRoith D, editors. Principles of endocrinology and hormone action, Chap 15. Switzerland: Springer; 2016. p. 387\u2013421. \n                    https:\/\/doi.org\/10.1007\/978-3-319-27318-1_16-1\n                    \n                  ."},{"issue":"1","key":"288_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41\u201350. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4\n                    \n                  .","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"288_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000314315","volume":"92","author":"MV Cicala","year":"2010","unstructured":"Cicala MV, Mantero F. Hypertension in Cushing\u2019s Syndrome: from pathogenesis to treatment. Neuroendocrinology. 2010;92(1):44\u20139. \n                    https:\/\/doi.org\/10.1159\/000314315\n                    \n                  .","journal-title":"Neuroendocrinology"},{"issue":"1","key":"288_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","volume":"33","author":"A Isidori","year":"2015","unstructured":"Isidori A, Graziadio C, Paragliola R, et al. The hypertension of Cushing\u02bcs syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens. 2015;33(1):44\u201360. \n                    https:\/\/doi.org\/10.1097\/HJH.0000000000000415\n                    \n                  .","journal-title":"J Hypertens"},{"issue":"3","key":"288_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56(3):331\u201349. \n                    https:\/\/doi.org\/10.1124\/pr.56.3.1\n                    \n                  .","journal-title":"Pharmacol Rev"},{"issue":"2","key":"288_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","volume":"32","author":"JWM Lenders","year":"2017","unstructured":"Lenders JWM, Eisenhofer G. Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab. 2017;32(2):152. \n                    https:\/\/doi.org\/10.3803\/EnM.2017.32.2.152\n                    \n                  .","journal-title":"Endocrinol Metab"},{"issue":"5","key":"288_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"J Funder","year":"2016","unstructured":"Funder J, Carey R, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916. \n                    https:\/\/doi.org\/10.1210\/jc.2015-4061\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"288_CR12","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW, et al. The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526\u201340. \n                    https:\/\/doi.org\/10.1210\/jc.2008-0125\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"288_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. \n                    https:\/\/doi.org\/10.1210\/jc.2014-1498\n                    \n                  .","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"288_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40292-016-0136-5","volume":"23","author":"C Sabbadin","year":"2016","unstructured":"Sabbadin C, Fallo F. Hyperaldosteronism: screening and diagnostic tests. High Blood Press Cardiovasc Prev. 2016;23(2):69\u201372. \n                    https:\/\/doi.org\/10.1007\/s40292-016-0136-5\n                    \n                  .","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"1","key":"288_CR15","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/EJE-17-0990","volume":"179","author":"TA Williams","year":"2018","unstructured":"Williams TA, Reincke M. MANAGEMENT OF ENDOCRINE DISEASE: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. Eur J Endocrinol. 2018;179(1):R19\u201329. \n                    https:\/\/doi.org\/10.1530\/EJE-17-0990\n                    \n                  .","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"288_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.beem.2010.10.007","volume":"24","author":"MV Cicala","year":"2010","unstructured":"Cicala MV, Mantero F. Primary aldosteronism: what consensus for the diagnosis. Best Pract Res Clin Endocrinol Metab. 2010;24(6):915\u201321. \n                    https:\/\/doi.org\/10.1016\/j.beem.2010.10.007\n                    \n                  .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"288_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab. 2006;91(2):454\u20139. \n                    https:\/\/doi.org\/10.1210\/jc.2005-1733\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"288_CR18","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2012-3934","volume":"98","author":"E Fischer","year":"2013","unstructured":"Fischer E, Adolf C, Pallauf A, et al. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrinol Metab. 2013;98(6):2513\u201320. \n                    https:\/\/doi.org\/10.1210\/jc.2012-3934\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"288_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-15-0450","volume":"173","author":"G Hanslik","year":"2015","unstructured":"Hanslik G, Wallaschofski H, Dietz A, et al. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. Eur J Endocrinol. 2015;173(5):665\u201375. \n                    https:\/\/doi.org\/10.1530\/EJE-15-0450\n                    \n                  .","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"288_CR20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1055\/s-0043-120524","volume":"49","author":"F Beuschlein","year":"2017","unstructured":"Beuschlein F, Mulatero P, Asbach E, et al. The SPARTACUS Trial: controversies and unresolved issues. Horm Metab Res. 2017;49(12):936\u201342. \n                    https:\/\/doi.org\/10.1055\/s-0043-120524\n                    \n                  .","journal-title":"Horm Metab Res"},{"issue":"7","key":"288_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","volume":"147","author":"Anne Marie Sinclair","year":"1987","unstructured":"Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med. 1987;147(7):1289\u201393. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3606286\n                    \n                  .","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"288_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"Gunnar H. Anderson","year":"1994","unstructured":"Anderson GH, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12(5):609\u201315. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7930562\n                    \n                  .","journal-title":"Journal of Hypertension"},{"issue":"3","key":"288_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4158\/ep.6.3.249","volume":"6","author":"M Ariton","year":"2018","unstructured":"Ariton M, Juan CS, AvRuskin TW. Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital. Endocr Pract. 2018;6(3):249\u201352. \n                    https:\/\/doi.org\/10.4158\/ep.6.3.249\n                    \n                  .","journal-title":"Endocr Pract"},{"issue":"3","key":"288_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1651-2227.1992.tb12213.x","volume":"81","author":"T Wyszy\u0144ska","year":"1992","unstructured":"Wyszy\u0144ska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr. 1992;81(3):244\u201346. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1511199\n                    \n                  .","journal-title":"Acta Paediatrica"},{"issue":"2","key":"288_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jcem.85.2.6372","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85(2):637\u201344. \n                    https:\/\/doi.org\/10.1210\/jcem.85.2.6372\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"288_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/jc.2014-2998","volume":"100","author":"M Lafont","year":"2015","unstructured":"Lafont M, Fagour C, Haissaguerre M, et al. Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab. 2015;100(2):417\u201321. \n                    https:\/\/doi.org\/10.1210\/jc.2014-2998\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"288_CR27","doi-asserted-by":"publisher","first-page":"G34","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175(2):G34. \n                    https:\/\/doi.org\/10.1530\/EJE-16-0467\n                    \n                  .","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"288_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11102-015-0634-9","volume":"18","author":"I Shimon","year":"2015","unstructured":"Shimon I. Screening for Cushing\u2019s syndrome: is it worthwhile? Pituitary. 2015;18(2):201\u20135. \n                    https:\/\/doi.org\/10.1007\/s11102-015-0634-9\n                    \n                  .","journal-title":"Pituitary"},{"issue":"3","key":"288_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40292-016-0153-4","volume":"23","author":"F Ceccato","year":"2016","unstructured":"Ceccato F, Boscaro M. Cushing\u2019s syndrome: screening and diagnosis. High Blood Press Cardiovasc Prev. 2016;23(3):209\u201315. \n                    https:\/\/doi.org\/10.1007\/s40292-016-0153-4\n                    \n                  .","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"9","key":"288_CR30","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1210\/jc.2009-0612","volume":"94","author":"M Boscaro","year":"2009","unstructured":"Boscaro M, Arnaldi G. Approach to the patient with possible Cushing\u2019s syndrome. J Clin Endocrinol Metab. 2009;94(9):3121\u201331. \n                    https:\/\/doi.org\/10.1210\/jc.2009-0612\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"288_CR31","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JOL, et al. Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab. 2013;98(6):2277\u201384. \n                    https:\/\/doi.org\/10.1210\/jc.2012-3582\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"key":"288_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1709-y","author":"D Hirsch","year":"2018","unstructured":"Hirsch D, Shimon I, Manisterski Y, et al. Cushing\u2019s syndrome: comparison between Cushing\u2019s disease and adrenal Cushing\u2019s. Endocrine. 2018. \n                    https:\/\/doi.org\/10.1007\/s12020-018-1709-y\n                    \n                  .","journal-title":"Endocrine"},{"issue":"3","key":"288_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193\u2013202. \n                    https:\/\/doi.org\/10.1291\/hypres.27.193\n                    \n                  .","journal-title":"Hypertens Res"},{"issue":"5","key":"288_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1210\/edrv.19.5.0346","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev. 1998;19(5):647\u201372. \n                    https:\/\/doi.org\/10.1210\/edrv.19.5.0346\n                    \n                  .","journal-title":"Endocr Rev"},{"issue":"3","key":"288_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12020-013-0112-y","volume":"46","author":"G Tirabassi","year":"2014","unstructured":"Tirabassi G, Boscaro M, Arnaldi G. Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine. 2014;46(3):370\u201386. \n                    https:\/\/doi.org\/10.1007\/s12020-013-0112-y\n                    \n                  .","journal-title":"Endocrine"},{"issue":"1","key":"288_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje-14-0061","volume":"171","author":"F Ceccato","year":"2014","unstructured":"Ceccato F, Antonelli G, Barbot M, et al. The diagnostic performance of urinary free cortisol is better than the cortisol: cortisone ratio in detecting de novo Cushing\u2019s syndrome: the use of a LC\u2013MS\/MS method in routine clinical practice. Eur J Endocrinol. 2014;171(1):1\u20137. \n                    https:\/\/doi.org\/10.1530\/eje-14-0061\n                    \n                  .","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"288_CR37","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2015-2507","volume":"100","author":"F Ceccato","year":"2015","unstructured":"Ceccato F, Barbot M, Zilio M, et al. Screening tests for Cushing\u2019s syndrome: urinary free cortisol role measured by LC\u2013MS\/MS. J Clin Endocrinol Metab. 2015;100(10):3856\u201361. \n                    https:\/\/doi.org\/10.1210\/jc.2015-2507\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"288_CR38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40618-017-0644-8","volume":"40","author":"F Ceccato","year":"2017","unstructured":"Ceccato F, Antonelli G, Frigo AC, et al. First-line screening tests for Cushing\u2019s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC\u2013MS\/MS. J Endocrinol Investig. 2017;40(7):753\u201360. \n                    https:\/\/doi.org\/10.1007\/s40618-017-0644-8\n                    \n                  .","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"288_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11102-011-0333-0","volume":"15","author":"H Raff","year":"2012","unstructured":"Raff H. Cushing\u2019s syndrome: diagnosis and surveillance using salivary cortisol. Pituitary. 2012;15(1):64\u201370. \n                    https:\/\/doi.org\/10.1007\/s11102-011-0333-0\n                    \n                  .","journal-title":"Pituitary"},{"issue":"1","key":"288_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/eje-13-0159","volume":"169","author":"F Ceccato","year":"2013","unstructured":"Ceccato F, Barbot M, Zilio M, et al. Performance of salivary cortisol in the diagnosis of Cushing\u2019s syndrome, adrenal incidentaloma, and adrenal insufficiency. Eur J Endocrinol. 2013;169(1):31\u20136. \n                    https:\/\/doi.org\/10.1530\/eje-13-0159\n                    \n                  .","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"288_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/EJE-11-0945","volume":"166","author":"T Deutschbein","year":"2012","unstructured":"Deutschbein T, Broecker-Preuss M, Flitsch J, et al. Salivary cortisol as a diagnostic tool for Cushing\u2019s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol. 2012;166(4):613. \n                    https:\/\/doi.org\/10.1530\/EJE-11-0945\n                    \n                  .","journal-title":"Eur J Endocrinol"},{"key":"288_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0921-1","author":"F Ceccato","year":"2018","unstructured":"Ceccato F, Marcelli G, Martino M, et al. The diagnostic accuracy of increased late night salivary cortisol for Cushing\u2019s syndrome: a real-life prospective study. J Endocrinol Investig. 2018. \n                    https:\/\/doi.org\/10.1007\/s40618-018-0921-1\n                    \n                  .","journal-title":"J Endocrinol Investig"},{"issue":"11","key":"288_CR43","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1210\/jc.2007-0596","volume":"92","author":"F Pecori Giraldi","year":"2007","unstructured":"Pecori Giraldi F, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cavagnini F. Specificity of first-line tests for the diagnosis of Cushing\u2019s syndrome: assessment in a large series. J Clin Endocrinol Metab. 2007;92(11):4123\u20139. \n                    https:\/\/doi.org\/10.1210\/jc.2007-0596\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"288_CR44","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1210\/jc.2008-0139","volume":"93","author":"MB Elamin","year":"2008","unstructured":"Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing\u2019s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93(5):1553\u201362. \n                    https:\/\/doi.org\/10.1210\/jc.2008-0139\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"288_CR45","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1210\/jc.2009-1500","volume":"94","author":"E Valassi","year":"2009","unstructured":"Valassi E, Swearingen B, Lee H, et al. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing\u2019s syndrome. J Clin Endocrinol Metab. 2009;94(12):4851\u20139. \n                    https:\/\/doi.org\/10.1210\/jc.2009-1500\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"288_CR46","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BMK, Findling JW, et al. Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807\u201331. \n                    https:\/\/doi.org\/10.1210\/jc.2015-1818\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"288_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/21678707.2015.991714","volume":"3","author":"F Ceccato","year":"2015","unstructured":"Ceccato F, Barbot M, Zilio M, Albiger N, Mantero F, Scaroni C. Therapeutic strategies for Cushing\u2019s syndrome: an update. Expert Opin Orphan Drugs. 2015;3(1):45\u201356. \n                    https:\/\/doi.org\/10.1517\/21678707.2015.991714\n                    \n                  .","journal-title":"Expert Opin Orphan Drugs"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-018-0288-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T19:24:57Z","timestamp":1573327497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-018-0288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s40292-018-0288-6","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,10]]},"assertion":[{"value":"11 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflicts of interest that might be perceived as influencing the impartiality of the reported research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Informed consent to describe patients\u2019 history has been obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and patient consent"}}]}}